SEC Tracker
Get the app

Dror Ortho-Design DROR

Dror Ortho-Design FY 2023: net loss $3.6M; diluted EPS −$0.01

Form
10-K/A
Filed
Period
Importance
Routine
Document
10-K/A

Key figures from this report

These are the numbers Dror Ortho-Design reported for the year ended Dec 31, 2023, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Net income−$3.6MAgainst −$179K in FY 202210-K income statement, on EDGAR
  2. Diluted EPS−$0.01Against $0.00 in FY 202210-K income statement, on EDGAR
  3. Cash and cash equivalents$3.3M+5978% from $55K in FY 202210-K balance sheet, on EDGAR
  4. Cash from operations−$2.4MAgainst −$131K in FY 202210-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Dror Ortho-Design files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3843 and related industry codes: the same peer list as the financial tables.

  1. Neuraxis NRXS public float $20M, Jun 30, 2025
  2. Allurion Technologies ALUR public float $21M, Jun 30, 2025
  3. Positron POSC public float $22M, Jun 30, 2025
  4. Vivos Therapeutics VVOS public float $23M, Jun 30, 2025
  5. Harvard Apparatus Regenerative Technology HRGN public float $16M, Jun 30, 2025